← Back to Search

Supportive Care for Chronic Kidney Disease

N/A

Recruiting

Led By Jennifer Scherer, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Documented diagnosis of Chronic Kidney Disease stage IV or V

Age ≥ 18

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 24

Awards & highlights

Study Summary

This trial tests whether integrated care visits improve symptoms, quality of life, and advance care planning for patients with advanced CKD.

Who is the study for?

This trial is for adults over 18 with advanced Chronic Kidney Disease (stage IV or V), including those on dialysis, who speak English or Spanish fluently. They must consent to participate and commit to the study's procedures for six months. People who've had palliative care recently, are pregnant, have urgent palliative needs, or can't understand the study due to cognitive issues cannot join.Check my eligibility

What is being tested?

The trial tests if adding supportive care visits to regular kidney disease outpatient appointments helps reduce symptoms and improve quality of life over six months. It also looks at whether this integrated approach increases engagement in planning future medical care.See study design

What are the potential side effects?

Since this intervention involves additional supportive care rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort discussing advance care planning.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My condition is chronic kidney disease at stage IV or V.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ability to Collect Planned Data

Average number of clinical visits attended per participant (Retention)

Change in Integrated Palliative Outcome Score-Renal (IPOS-Renal) Score

+3 more

Secondary outcome measures

Change in Kidney Disease Quality of Life (KDQOL-36) Score

Engagement in Advance Care Planning

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Supportive Care InterventionExperimental Treatment1 Intervention

The supportive care intervention arm will receive their usual ambulatory longitudinal nephrology care integrated with ambulatory supportive care through monthly supportive care visits over six months.

Group II: Usual Care ControlActive Control1 Intervention

The usual care control arm will be seen at the discretion of their nephrologist, or receive their usual dialysis if on dialysis.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,368 Previous Clinical Trials

839,646 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,358 Previous Clinical Trials

4,315,161 Total Patients Enrolled

Jennifer Scherer, MDPrincipal InvestigatorNYU Langone Health

1 Previous Clinical Trials

45 Total Patients Enrolled

Media Library

Integrated Palliative Care Clinical Trial Eligibility Overview. Trial Name: NCT04998110 — N/A

Chronic Kidney Disease Research Study Groups: Supportive Care Intervention, Usual Care Control

Chronic Kidney Disease Clinical Trial 2023: Integrated Palliative Care Highlights & Side Effects. Trial Name: NCT04998110 — N/A

Integrated Palliative Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04998110 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any additional participants being sought for this clinical trial?

"According to the clinicaltrials.gov listing, this medical study is still in search of volunteers. The trial was originally listed on May 1st 2022 and most recently updated by February 23rd 2022."

Answered by AI

What is the enrollment count for this clinical trial?

"Indeed, the details on clinicaltrials.gov verify that this trial is presently engaging candidates. It was initially posted on 5th January 2022 and has been revised to its current form as of 23rd February 2022. The medical study demands 80 subjects from one centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Integrated Palliative Care With Nephrology Care

2022. "Integrated Palliative Care With Nephrology Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04998110.